Monday, November 28, 2016 7:28:02 AM
Nov 28 (Reuters) - Idera Pharmaceuticals Inc(IDRA) :
* Press release - Idera Pharmaceuticals(IDRA) and Vivelix Pharmaceuticals, Ltd. Enter into exclusive license agreement for the worldwide rights to IMO-9200
* Idera Pharmaceuticals Inc(IDRA) - under terms of agreement, idera will receive an upfront fee of $15 million
* Idera Pharmaceuticals Inc(IDRA) - will be eligible for future imo-9200 related development, regulatory and sales milestone payments totaling up to $140 million
* Idera Pharmaceuticals Inc(IDRA) - will be eligible for escalating royalties ranging from mid single-digits to low double-digits of global net sales
* Idera Pharmaceuticals Inc(IDRA) -under terms, idera is responsible for developing potential back-up compounds to imo-9200
* Idera Pharmaceuticals(IDRA) - idera will be eligible for related development, regulatory sales and milestone payments totaling up to $52.5 million
* Idera Pharmaceuticals Inc(IDRA) - as part of agreement, idera has agreed to create and characterize potential back-up compounds for vivelix Source text for Eikon: Further company coverage:
(c) Copyright Thomson Reuters 2016. Click For Restrictions - about.reuters.com/fulllegal.asp
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM